It is a retrospective cross sectional study of Caesarean sections conducted in a tertiary care centre in the present millennium. The study is conducted to ascertain the 1) Incidence 2) Indications 3) Fetal and maternal outcomes & complications. All caesarean sections conducted at the Regional Institute of Medical Sciences Hospital Imphal during the period January 2003 to December 2003 were included. Data was analysed using simple mathematical calculations. Two thousand and twenty-four caesarean deliveries were conducted out of total of 10,483 deliveries. There were 2 maternal deaths and 17 fetal/neonatal deaths. The incidence of caesarean deliveries is on the rise. In spite of much advancement in the present day medical care and obstetric care, caesarean deliveries still carry significant risk to the mother as well as to the newborns, and much more have to be done to improve outcome.
Misoprostol, a synthetic PGE₁, analogue may be used for induction of labour. It is a preliminary study to evaluate the efficacy and safety of intravaginal insertion of misoprostol 50ugm tablet for induction of labour. A total of 110 consecutive cases of singleton term pregnancy with cephalic presentation having Bishops cervical score ≤ 4 were included. Cases of CPD, placenta praevia, previous uterine scars and twin conceptions were excluded. Ninety-six women had vaginal delivery and 14 cases had caesarean deliveries. Average induction delivery interval was 10.8 ± 4.8 hours. Apgar score of newborn at 1 minute was 8.86 ± 0.735. Induction of labour with single dose of 50 µgm of misoprostol vaginally is effective as other inducing agents with no obvious side-effects to both mothers and newborns
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.